American Cancer Society Report is Misleading; younger women getting more triple negative, estrogen positive & HER2+ breast cancers

Women of childbearing age, in many states around the U.S. today, face historically high invasive breast cancer levels. The American Cancer Society’s (ACS’) recent study, published Feb 22, in the American Association for Cancer Research, is incorrect when it says breast cancer rates are not changing for younger women.

In Massachusetts, younger women (under 50), saw a 45% increase in invasive breast cancer between 1995-2007; younger women in Colorado saw a 27% increase between 1990-2008, and younger women in Florida saw a 40% increase between 1984-2008.

The American Cancer Society’s February, 2011 report doesn’t count the actual number of women diagnosed in each state; instead, it uses an estimate, based on a formula, based on 9% of the U.S. population.

To know the real story, we need to count every woman who is affected, and we need to have those numbers published for all of us to see and understand.

Contact you state cancer board and ask them how many younger women developed invasive breast cancers last year, compared to the past five or ten years. Also ask them, how many of these younger women were diagnosed with triple negative, HER2+ and estrogen receptor positive breast cancers.

We need this specific information, not estimates. Keeping women in the dark when it comes to these critical numbers, makes it impossible to measure any positive changes, as women try easy and healthy ways to stop breast cancer before it starts.

U. S. Breast Cancer Epidemic Hitting Young Moms and Other Women of Childbearing Age

In   2009, about 62,520 women of childbearing age in the United States were diagnosed with invasive breast cancer.  This is a whopping 41% increase from 2001, when approximately 44, 300 women of childbearing age were reportedly diagnosed with the disease, according to recent American Cancer Society statistics.

These younger American women are being hit with triple negative, HER2 positive and estrogen positive breast cancers; diseases  that usually maim, sometimes kill and often bankrupt a woman’s current and future financial situation.

In recent years young media leaders and celebrities have shared their personal breast cancer diagnoses, including Fox News political reporter Jennifer Griffin (triple negative); ABC’s Good Morning America host,  Robin Roberts (triple negative); National Public Radio’s Tavis Smiley Show Executive Producer,  Sheryl Flowers, who died from triple negative breast cancer in 2009 at the age of 42, folksinger Melissa Ethridge (HER2 positive) and film star, Christina Applegate.

Why is this new epidemic happening to our younger women? How can younger women help stop breast cancer from happening to them ever… or never again?

For more information on why younger women in the U.S. are facing this current breast cancer epidemic, and for specific ways each woman can help lower her risk of developing breast cancer ever… or never again, sign on to The Truth About Breast Cancer blog  http://www.thetruthaboutbreastcancer.com
visit   http://www.knowbreastcancer.net become a Facebook fan and Twitter.

Taking Tamoxifen or using birth control drugs can increase risk of triple negative breast cancer 4-fold

May 6, 2010

Manchester by the Sea, MA

A woman’s risk of developing aggressive triple negative breast cancer seems to increase 4- fold for individuals who are either taking birth control drugs or are taking the breast cancer drug, Tamoxifen.

Both pieces of research out of the Seattle- based Fred Hutchinson Cancer Research Center and published in different scientific journals in 2009,  include important facts for women who are currently using either of these drugs, or considering the use of either drug.

Unfortunately neither the American Cancer Society, nor Susan G. Komen for the Cure have yet to  mention either of these recent and alarming studies on their websites as  of May 7, 2010.

WHY??

If the American Cancer Society is  considered by many to be our unofficial  national cancer prevention organization ; if Susan G Komen is considered to be  our leading national non profit on breast cancer education,  why isn’t either group sounding an alarm about using birth control drugs or using Tamoxifen?

A possible answer: Pharmaceutical companies that make billions from contraceptive drugs and billions from the sale of Tamoxifen each year,  also give hundreds of millions to the American Cancer Society and to  Komen each year.  Perhaps, these  non-profits  are unwilling  to bite the hands that feed them.

Meanwhile,   younger  women who use birth control drugs, and older women who remain on the drug Tamoxifen,   are left more vulnerable than other women for developing triple negative breast cancer,   a fast-growing cancer,   when it develops in younger women. Meanwhile, the disease  continues to affect more and more women of all ages, each year, in the United States.

Triple Negative now represents 15% to 20% of all new invasive breast cancer diagnoses, striking younger women more often than older women and striking a disproportionate number of younger black women compared to  white women.

Research studies  cited in today’s post:

Jennifer Dolle, et al, Risk Factors for Triple Negative Breast Cancer in Women Under the Age of 45 Years , Cancer, Epidemiology, Biomarkers, and Prevention, 2009; 18 (4) April 2009.

Christopher Li, MD PhD, Long-term tamoxifen use increases the risk of an aggressive, difficult to treat type of second breast cancer, Cancer Research, August 25, 2009,